{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:31Z","timestamp":1791415951572,"version":"4.3.3"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019557","name":"Universidade Estadual do Maranh\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.arcmed.2024.103084","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T19:52:45Z","timestamp":1727380365000},"page":"103084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["New Drugs and Promising Drug Combinations in the Treatment of Chagas Disease in Brazil: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"56","author":[{"given":"Elainne Silva","family":"Freire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Pinto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-6138","authenticated-orcid":false,"given":"Aline do Carmo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-7610","authenticated-orcid":false,"given":"Pedro Alves Soares","family":"Vaz de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-5087","authenticated-orcid":false,"given":"Giovanna Rotondo","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayane Andriotti","family":"Otta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-201X","authenticated-orcid":false,"given":"Danilo Cavalcante","family":"Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-6217","authenticated-orcid":false,"given":"Juliana Maria Trindade","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.103084_bib0001","first-page":"240","article-title":"Avalia\u00e7\u00e3o Card\u00edaca na fase aguda da doen\u00e7a de Chagas com evolu\u00e7\u00e3o p\u00f3s-tratamento em pacientes atendidos no estado do Amazonas, Brasil","volume":"112","author":"Ortiz","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0002","first-page":"1900","article-title":"Esterol 14\u03b1-desmetilase de trypanosomatidae parasitas como um alvo promissor para o desenho de novos agentes Antiparasit\u00e1rios","volume":"21","author":"Santos-J\u00fanior","year":"2021","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.arcmed.2024.103084_bib0003","unstructured":"LAFEPE, medicamentos. 2018. Modelo de bula para os profissionais de sa\u00fade 2018. Available in: https:\/\/www.lafepe.pe.gov.br\/wp-content\/uploads\/2018\/08\/benznidazol_bula_paciente_bilingue.pdf. (Accessed 12 December 2023."},{"key":"10.1016\/j.arcmed.2024.103084_bib0004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1590\/1414-462x201900030456","article-title":"Rea\u00e7\u00f5es adversas ao benzonidazol no tratamento da Doen\u00e7a de Chagas: revis\u00e3o sistem\u00e1tica de ensaios cl\u00ednicos randomizados e controlados","volume":"27","author":"Ferreira","year":"2019","journal-title":"Cad Sa\u00fade Colet"},{"key":"10.1016\/j.arcmed.2024.103084_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.12662\/2317-3076jhbs.v5i2.1135.p130-136.2017","article-title":"Perfil hematol\u00f3gico e bioqu\u00edmico de pacientes com doen\u00e7a de Chagas atendidos por um servi\u00e7o de aten\u00e7\u00e3o farmac\u00eautica no estado do Cear\u00e1","volume":"5","author":"Silva Filho","year":"2017","journal-title":"J Health Biol Sci"},{"key":"10.1016\/j.arcmed.2024.103084_bib0006","series-title":"Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias No SUS (CONITEC)","article-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas doen\u00e7a de Chagas","year":"2018"},{"key":"10.1016\/j.arcmed.2024.103084_bib0007","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/civ690","article-title":"Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease","volume":"61","author":"Salvador","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2024.103084_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041960","article-title":"Pharmacogenomic profile and adverse drug reactions in a prospective therapeutic cohort of chagas disease patients treated with Benznidazole","volume":"22","author":"Franco","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2024.103084_bib0009","first-page":"1","article-title":"Advances in the treatment of Chagas disease: promising new drugs, plants, and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2020","journal-title":"Biomed Pharmacot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0010","first-page":"7","article-title":"II Consenso Brasileiro em doen\u00e7a de Chagas","volume":"25","author":"Dias","year":"2015","journal-title":"Epidemiol Serv Sa\u00fade 2016"},{"key":"10.1016\/j.arcmed.2024.103084_bib0011","series-title":"Secretaria De Vigil\u00e2ncia em Sa\u00fade","article-title":"Doen\u00e7a de Chagas","year":"2021"},{"key":"10.1016\/j.arcmed.2024.103084_bib0012","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1017\/S0031182021001001","article-title":"Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease Treatment","volume":"148","author":"Mazzeti","year":"2021","journal-title":"Parasit"},{"key":"10.1016\/j.arcmed.2024.103084_bib0013","series-title":"Novo Acordo Da Fiocruz com a Bayer visa Oferecer Refor\u00e7o Ao Tratamento Da Doen\u00e7a De Chagas","year":"2023"},{"key":"10.1016\/j.arcmed.2024.103084_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.10.030","article-title":"Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres","volume":"26","author":"Crespillo-And\u00fajar","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.arcmed.2024.103084_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-022-00742-w","article-title":"Nifurtimox for treatment of Chagas disease in pediatric patients: the challenges of applying pharmacokineticpharmacodynamic principles to dose finding","volume":"24","author":"Stass","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.arcmed.2024.103084_bib0016","first-page":"184","article-title":"Chronic heart disease after treatment of oral acute Chagas disease","volume":"107","author":"Antunes","year":"2015","journal-title":"Chagas Dis Arq Bras Cardiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0017","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0036-46652015000200008","article-title":"Clinical and epidemiological profile of elderly patients with Chagas disease followed between 2005 and 2013 by pharmaceutical care service in Cear\u00e1 state, northeastern Brazil","volume":"57","author":"Pereira","year":"2015","journal-title":"Rev Med Trop"},{"key":"10.1016\/j.arcmed.2024.103084_bib0018","first-page":"99","article-title":"Evolu\u00e7\u00e3o cl\u00ednica p\u00f3s-implante de desfibrilador card\u00edaco: pacientes chag\u00e1sicos versus isqu\u00eamicos","volume":"107","author":"Pereira","year":"2016","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36660\/abc.20230269","article-title":"Diretriz da SBC sobre diagn\u00f3stico e tratamento de pacientes com cardiomiopatia da doen\u00e7a de Chagas\u20132023","volume":"120","author":"Marin-Neto","year":"2023","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1590\/S0080-62342011000500033","article-title":"Revis\u00e3o sistem\u00e1tica: no\u00e7\u00f5es gerais","volume":"45","author":"De-La-Torre-Urgate-Guanilo","year":"2011","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.arcmed.2024.103084_bib0021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0104-11692004000300014","article-title":"Revis\u00e3o sistem\u00e1tica: recurso que proporcionar a incorpora\u00e7\u00e3o das evid\u00eancias na pr\u00e1tica da enfermagem","volume":"12","author":"Galv\u00e3o","year":"2004","journal-title":"Rev Lat Am Enferm"},{"key":"10.1016\/j.arcmed.2024.103084_bib0022","series-title":"Promising New Drugs in the Treatment of Chagas disease: a Systemic Review","year":"2021"},{"key":"10.1016\/j.arcmed.2024.103084_bib0023","unstructured":"INTERNATIONAL PROSPECTIVE REGISTER OF SYSTEMATIC REVIEWS (PROSPERO), 2021. Promising new drugs in the treatment of Chagas disease: a systemic review. Available in: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021238146. (Accessed 25 January 2024)."},{"key":"10.1016\/j.arcmed.2024.103084_bib0024","first-page":"1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2024.103084_bib0025","series-title":"Checklist For Systematic Reviews and Research Syntheses","year":"2020"},{"key":"10.1016\/j.arcmed.2024.103084_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0238339","article-title":"Effects of temperature and humidity on the spread of COVID-19: a systematic review","volume":"15","author":"Mecenas","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arcmed.2024.103084_bib0027","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.exppara.2008.08.002","article-title":"Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice","volume":"12","author":"Francisco","year":"2008","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"Diniz","year":"2013","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.arcmed.2024.103084_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003207","article-title":"Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of Chagas disease","volume":"8","author":"Sesti-Costa","year":"2014","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.arcmed.2024.103084_bib0030","first-page":"1","article-title":"Benznidazole\/itraconazole combination treatment enhances anti-Trypanosoma cruzi activity in experimental Chagas disease","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arcmed.2024.103084_bib0031","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/MJT.0000000000000137","article-title":"Impact of the use of benznidazole followed by antioxidant supplementation in the prevalence of ventricular arrhythmias in patients with chronic Chagas disease: pilot study","volume":"23","author":"Barbosa","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.arcmed.2024.103084_bib0032","first-page":"2425","article-title":"In vitro and in vivo trypanosomicidal action of novel arylimidamides against trypanosoma cruzi","volume":"60","author":"Guedes-da-Silva","year":"2016","journal-title":"Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0033","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/AAC.00343-16","article-title":"Curcumin enhances the anti- trypanosoma cruzi activity of benznidazole-based chemotherapy in acute experimental Chagas disease","volume":"60","author":"Novaes","year":"2016","journal-title":"Antimicrobial Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0034","first-page":"4297","article-title":"Combination chemotherapy with suboptimal doses of benznidazole and pentoxifylline sustains partial reversion of experimental Chagas\u2019 heart disease","volume":"60","author":"Vilar-Pereira","year":"2016","journal-title":"Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0035","first-page":"1","article-title":"Repurposing strategy of atorvastatin against trypanosoma cruzi: in vitro monotherapy and combined therapy with benznidazole exhibit synergistic trypanocidal activity","volume":"62","author":"Ara\u00fajo-Lima","year":"2018","journal-title":"Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0036","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/0037-8682-0285-2017","article-title":"Evaluation of in vitro anti-trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination","volume":"51","author":"Louren\u00e7o","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.arcmed.2024.103084_bib0037","first-page":"1","article-title":"Benefits of ascorbic acid in association with low-dose benznidazole in treatment of Chagas disease","volume":"62","author":"Providello","year":"2018","journal-title":"Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-021-03248-8","article-title":"Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II","volume":"21","author":"Sarto","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.arcmed.2024.103084_bib0039","first-page":"10","article-title":"Experimental combination therapy with amiodarone and low-dose benznidazole in a mouse model of Trypanosoma cruzi acute infection","volume":"10","author":"Barbosa","year":"2022","journal-title":"Espectro Microbiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2022.975931","article-title":"Benznidazole and amiodarone combined treatment attenuate cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells","volume":"12","author":"Barbosa","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0041","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exppara.2019.02.016","article-title":"Cordycepin (3\u2032-deoxyadenosine) and pentostatin (deoxycoformycin) against Trypanosoma cruzi","volume":"199","author":"Carmo","year":"2019","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0042","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0074-02762008000300007","article-title":"A potent trypanocidal component from the fungus Lentinus strigous inhibits trypanothione reductase and modulates PBMC proliferation","volume":"103","author":"Cota","year":"2008","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.arcmed.2024.103084_bib0043","first-page":"4694","article-title":"Pharmacological inhibition of transforming growth factor \u03b2 signaling decreases infection and prevents heart damage in acute Chagas disease","volume":"53","author":"Waghabi","year":"2009","journal-title":"Ant Age Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-5-352","article-title":"Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi","volume":"5","author":"Aleixo","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.arcmed.2024.103084_bib0045","first-page":"1032","article-title":"Antiprotozoal activity of the cyclopalladated complexes against leishmania amazonenses and trypanosoma cruzi","volume":"27","author":"Vel\u00e1squez","year":"2016","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.arcmed.2024.103084_bib0046","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2019.05.001","article-title":"Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi","volume":"176","author":"Ferreira","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.arcmed.2024.103084_bib0047","first-page":"1","article-title":"Effects of ghrelin supplementation on the acute phase of Chagas disease in rats","volume":"12","author":"Silva","year":"2019","journal-title":"Parasites Vect"},{"key":"10.1016\/j.arcmed.2024.103084_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0074-02760190389","article-title":"Antiparasitic and anti-inflammatory activities of \u00df-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection","volume":"115","author":"Cascabulho","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.arcmed.2024.103084_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27228087","article-title":"Phenotypic evaluation of nucleoside analogues against trypanosoma cruzi infection: in vitro and in vivo approaches","volume":"27","author":"Fiuza","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arcmed.2024.103084_bib0050","first-page":"1","article-title":"Synthesis, design, and structure-activity relationship of a benzenesulfonylpiperazine series against trypanosoma cruzi","volume":"17","author":"Martinho","year":"2022","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.arcmed.2024.103084_bib0051","first-page":"65","article-title":"Insights from the use of erythropoietin in experimental Chagas disease","volume":"19","author":"Nobre","year":"2022","journal-title":"Int J Parasitol: Drugs Drug Resist"},{"key":"10.1016\/j.arcmed.2024.103084_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2019.151060","article-title":"Induction of autophagy of host cells triggers defense mechanisms against Trypanosoma cruzi infection in vitro","volume":"99","author":"Duque","year":"2020","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01834-17","article-title":"Identification of anti-trypanosoma cruzi lead compounds with putative immunomodulatory activity","volume":"62","author":"Otta","year":"2018","journal-title":"Antimicr Agents Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.54751\/revistafoco.v16n6-158","article-title":"An\u00e1lise farmacocin\u00e9tica e farmacodin\u00e2mica in Sil\u00edcio do Eucaptol","volume":"16","author":"Pinheiro","year":"2023","journal-title":"Rev Foco"},{"key":"10.1016\/j.arcmed.2024.103084_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-23941-z","article-title":"Fexinidazole interferes with the growth and structural organization of Trypanosoma cruzi","volume":"12","author":"Zuma","year":"2022","journal-title":"Rep Sci"},{"key":"10.1016\/j.arcmed.2024.103084_bib0056","first-page":"1","article-title":"Extracellular vesicles in Chagas disease: a new passenger for an old disease","volume":"9","author":"Torr\u00f3","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0057","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0034-89101986000200003","article-title":"Comportamento sangu\u00edcolas do Tripanosoma cruzi obtidas de camundongos utilizados como filtros biol\u00f3gicos, em culturas e em triatom\u00edneos","volume":"20","author":"Ribeiro","year":"1986","journal-title":"Rer Sa\u00fade P\u00fabl"},{"key":"10.1016\/j.arcmed.2024.103084_bib0058","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1590\/S0037-86821997000100006","article-title":"Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology","volume":"30","author":"Andrade","year":"1997","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.arcmed.2024.103084_bib0059","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0037-86821991000400002","article-title":"Estudo do comportamento de cepas Trypanosoma cruzi ap\u00f3s passagem em diferentes esp\u00e9cies de triatom\u00edneos","volume":"24","author":"Magalh\u00e3es","year":"1991","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.arcmed.2024.103084_bib0060","first-page":"1","article-title":"Targeting host mitochondria: a role for the Trypanosoma cruzi amastigote flagellum","volume":"20","author":"Lentini","year":"2017","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0061","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1128\/AAC.02754-13","article-title":"Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease","volume":"58","author":"Bahia","year":"2014","journal-title":"Antimicr Agents Chemot"},{"key":"10.1016\/j.arcmed.2024.103084_bib0062","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exppara.2017.02.015","article-title":"Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels","volume":"176","author":"Dinesh","year":"2017","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0063","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2165\/00003495-200464180-00001","article-title":"Newer systemic antifungal agents: pharmacokinetics, safety and efficacy","volume":"64","author":"Boucher","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.arcmed.2024.103084_bib0064","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7705\/biomedica.5187","article-title":"Sensibilidad in vitro a benznidazol, nifurtmox y posaconazol de cepas de Trypanosoma cruzi de Paraguay","volume":"40","author":"Acosta","year":"2020","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.arcmed.2024.103084_bib0065","series-title":"Secret\u00e1ria De Ci\u00eancia, Tecnologia, Inova\u00e7\u00e3o, e Insumos Estrat\u00e9gicos Em Sa\u00fade","year":"2022"},{"key":"10.1016\/j.arcmed.2024.103084_bib0066","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1054-8807(93)90021-S","article-title":"Correlation between trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings","volume":"2","author":"Higuchi","year":"1993","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0067","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s43018-022-00335-8","article-title":"Bystander T cells in cancer immunology and therapy","volume":"3","author":"Meier","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.arcmed.2024.103084_bib0068","doi-asserted-by":"crossref","first-page":"132","DOI":"10.36660\/abc.20200330","article-title":"Treinamento com exerc\u00edcio f\u00edsico e doen\u00e7a de chagas: fun\u00e7\u00e3o potencial dos MicroRNAs","volume":"117","author":"Improta-Caria","year":"2021","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.arcmed.2024.103084_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.866120","article-title":"Role of the PD-1\/PD-L1 pathway in experimental trypanosoma cruzi infection and potential therapeutic options","volume":"13","author":"Arana","year":"2022","journal-title":"Front Immunol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092400136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092400136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T21:29:55Z","timestamp":1737581395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844092400136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S018844092400136X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103084","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Drugs and Promising Drug Combinations in the Treatment of Chagas Disease in Brazil: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103084"}}